http://www.sciepub.com/journal/IJCD International Journal of Celiac Disease is an international scientific journal that publishes editorials, review article, short communications, original papers, case reports in English language. Journal publishes all works, that should be helpful in postgraduate educations of all professionals, who are interesting in celiac disease. Topics of the journal are problems of celiac disease and all of otherwise related texts in a broad of all medicine and other scientific fields. The main objective of Journal is publishing qualitative manuscripts with interesting information for clinical practice and for various researches. Editorial Board would like kindly invite all-world authors to send their manuscript for peer review. Journal is this time in the evaluation of some external databases with searching for IF.

All authors are responsible for submitting manuscripts in comprehensible US or UK English and ensuring scientific accuracy. International Journal of Celiac Disease subscribes to the Principles of Transparency and Best Practice in Scholarly Publishing developed by The Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME).

Manuscript format must be in accordance with the ICMJE-Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. Science and Education Publishing en 2013 Science and Education Publishing Co. Ltd All rights reserved. International Journal of Celiac Disease 13 1 January 2025 2013 Science and Education Publishing Co. Ltd All rights reserved. http://pubs.sciepub.com/ijcd/13/1/1 Fatemeh Elham Mahjoub, Mehrnaz Farasat, Mehri Najafi Sani, Azizollah Yousefi, Pegah Pakzadian, Fatemeh Farahmand, Farzaneh Moatamed, Pejman Rohani, Shahindoqht Homayoun Valiane, Alireza Nourbakhsh, Touran Akbari 2025-07-14 Science and Education Publishing 2025-07-14 1 13 1 3 10.12691/ijcd-13-1-1 http://pubs.sciepub.com/ijcd/13/1/2 in vitro but may not be involved in cell-mediated immune reactions in CD. These reactions are related to tyrosine-containing peptides. Further along the chain is peptide 75-86, the most tissue damaging of the A-gliadin peptides in CD patients. This peptide is a tyrosine-containing peptide where damage caused to mucosal tissue is greater in CD than in NCGS. Hence, although CD and NCGS are both caused by gluten, the pathogenesis of the diseases has different mechanisms. However, both serine-containing and tyrosine-containing peptides are attacked by caricain, the protective enzyme in GluteGuard, thus rendering both types of toxic peptides harmless to the intestinal mucosa of susceptible individuals. Just as has been seen with Dermatitis Herpetiformis (DH), gluten is becoming a focus for several conditions when the neurological effects of gluten need to be considered.]]> Hugh J. Cornell, Teodor Stelmasiak 2025-08-18 Science and Education Publishing 2025-08-18 1 13 4 9 10.12691/ijcd-13-1-2